title: Immunotherapeutic approaches against Staphylococcus aureus.
abstract: Staphylococcus aureus is a major cause of life-threatening infections such as bacteremia and endocarditis. Unfortunately, many strains of this bacterial species have become resistant to certain antibiotics, including methicillin and amoxicillin. These strains are known as methicillin-resistant S. aureus (MRSA). Therefore, the prophylactic and therapeutic potential of antistaphylococcal vaccines is currently being explored with priority. In animal models, (passive) immunization with (antibodies directed against) certain S. aureus surface components, staphylococcal toxins and capsular polysaccharides protects against S. aureus colonization or infection. However, immunization studies performed in humans show less promising results. So far, not a single antistaphylococcal vaccine successfully passed clinical trials. This article focuses on the results that were obtained with immunotherapeutic approaches directed against S. aureus in animal and human studies. In addition, it is discussed whether effective immunization approaches against S. aureus are feasible in humans.
authors.affiliation: Erasmus Medical Center, Department of Medical Microbiology & Infectious Diseases's, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. n.j.verkaik@erasmusmc.nl
authors.forename: Nelianne J
authors.initials: NJ
authors.lastname: Verkaik
authors.forename: Willem J B
authors.initials: WJ
authors.lastname: van Wamel
authors.forename: Alex
authors.initials: A
authors.lastname: van Belkum
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D007114:Immunization; D007167:Immunotherapy; D013203:Staphylococcal Infections / Q000276:immunology / Q000628:therapy*; D013209:Staphylococcal Vaccines / Q000276:immunology*; D013211:Staphylococcus aureus / Q000276:immunology*
chemical_list: D013209:Staphylococcal Vaccines